Pharming Group Financials
| PHARM Stock | EUR 0.83 0.02 2.35% |
Pharming |
Please note, the presentation of Pharming Group's financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Pharming Group's management is honest, while the outside auditors are strict and uncompromising. Please utilize our Beneish M Score to check the likelihood of Pharming Group's management manipulating its earnings.
Pharming Group Stock Summary
Pharming Group competes with Galapagos, Koninklijke BAM, Fugro NV, PostNL NV, and AMG Advanced. Pharming Group N.V., a specialty pharmaceutical company, develops and manufactures biopharmaceutical products in the United States, Europe, and internationally. Pharming Group N.V. is headquartered in Leiden, the Netherlands. PHARMING GROUP operates under Biotechnology classification in Netherlands and is traded on Amsterdam Stock Exchange. It employs 183 people.| Foreign Associate | Sweden |
| Instrument | Netherlands Stock View All |
| Exchange | Euronext Amsterdam |
| ISIN | NL0010391025 |
| Business Address | Darwinweg 24, Leiden, |
| Sector | Healthcare |
| Industry | Biotechnology |
| Benchmark | Dow Jones Industrial |
| Website | www.pharming.com |
| Phone | 31 71 524 7400 |
| Currency | EUR - Euro |
You should never invest in Pharming Group without having analyzed its financial statements. Do not rely on someone else's analysis or guesses about the future performance of Pharming Stock, because this is throwing your money away. Analyzing the key information contained in Pharming Group's financial statements can give you an edge over other investors and help to ensure that your investments perform well for you.
Pharming Group Key Financial Ratios
Pharming Group's financial ratios allow both analysts and investors to convert raw data from Pharming Group's financial statements into concise, actionable information that can be used to evaluate the performance of Pharming Group over time and compare it to other companies across industries.| Return On Equity | 0.17 | |||
| Return On Asset | 0.0643 | |||
| Target Price | 8.02 | |||
| Number Of Employees | 277 | |||
| Beta | 0.98 |
Pharming Financial Ratios Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Pharming Group's current stock value. Our valuation model uses many indicators to compare Pharming Group value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Pharming Group competition to find correlations between indicators driving Pharming Group's intrinsic value. More Info.Pharming Group NV is considered to be number one stock in return on equity category among its peers. It also is considered to be number one stock in return on asset category among its peers reporting about 0.39 of Return On Asset per Return On Equity. The ratio of Return On Equity to Return On Asset for Pharming Group NV is roughly 2.60 . Comparative valuation analysis is a catch-all model that can be used if you cannot value Pharming Group by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Pharming Group's Stock. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued.Pharming Group NV Systematic Risk
Pharming Group's systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. Pharming Group volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
The function did not generate any output. Please change time horizon or modify your input parameters. The output start index for this execution was one with a total number of output elements of sixty. The Beta measures systematic risk based on how returns on Pharming Group NV correlated with the market. If Beta is less than 0 Pharming Group generally moves in the opposite direction as compared to the market. If Pharming Group Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one Pharming Group NV is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of Pharming Group is generally in the same direction as the market. If Beta > 1 Pharming Group moves generally in the same direction as, but more than the movement of the benchmark.
Pharming Group December 17, 2024 Opportunity Range
Along with financial statement analysis, the daily predictive indicators of Pharming Group help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Pharming Group NV. We use our internally-developed statistical techniques to arrive at the intrinsic value of Pharming Group NV based on widely used predictive technical indicators. In general, we focus on analyzing Pharming Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Pharming Group's daily price indicators and compare them against related drivers.
| Downside Deviation | 3.52 | |||
| Information Ratio | 0.0794 | |||
| Maximum Drawdown | 20.57 | |||
| Value At Risk | (3.85) | |||
| Potential Upside | 6.02 |
Complementary Tools for Pharming Stock analysis
When running Pharming Group's price analysis, check to measure Pharming Group's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Pharming Group is operating at the current time. Most of Pharming Group's value examination focuses on studying past and present price action to predict the probability of Pharming Group's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Pharming Group's price. Additionally, you may evaluate how the addition of Pharming Group to your portfolios can decrease your overall portfolio volatility.
| Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
| Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites |